Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Merck

Cyberwar continues to underperform

Episode 487 of the Cyberlaw Podcast

Reason

Dow Jones Drops 150 Points On Strong Retail Sales; Apple, Nvidia, Tesla Sell Off

The Dow Jones dropped 150 points Wednesday on strong retail sales data. Apple, Nvidia and Tesla stock sold off.

Investors Business Daily

Dow Jones Falls 250 Points As Goldman Sachs Rallies On Earnings; Apple Tumbles On iPhone Discounts

The Dow Jones dropped 250 points Tuesday as Goldman Sachs fell on earnings. Apple stock sold off on iPhone discounts in China.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

These 9 Stocks Are Running To Start 2024

The S&P 500 rebounded last week near record highs, but is up just 0.2% so far in 2024. These are the index's top performers so far.

Investors Business Daily

Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space

There's a revolution in immunology that could completely shift a paradigm biotech stocks. And Big Pharma is paying billions to get in.

Investors Business Daily

Dow Jones Falls On Cool Inflation Data; Tesla Stock Slides Despite Cathie Wood Buys

The Dow Jones fell Friday after key inflation data. Tesla stock dived on China price cuts despite Cathie Wood's new purchases.

Investors Business Daily

Dow Jones Slides 225 Points On Hot Inflation Report; Nvidia Reverses From Record Highs

The Dow Jones Industrial Average dropped 225 points Thursday on a hot CPI inflation report. Nvidia stock reversed from more record highs.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Rises As Goldman Sachs Downgraded; Bitcoin Stock Coinbase Slides

The Dow Jones rose Wednesday, as Wall Street awaits Thursday's CPI data. GS stock was downgraded, while bitcoin stock Coinbase fell.

Investors Business Daily

Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot'

Cancer-focused biotech companies Ambrx and Harpoon snapped up a pair of takeover deals. AMAM stock and HARP stock soared.

Investors Business Daily

Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?

Merck stock is shrugging off seven months of underperformance, shooting more than 7% higher in the first week of 2024.

Investors Business Daily

Merck Hooks Harpoon Therapeutics in 0M Acquisition Spree!

Merck sets sail into new therapeutic waters with the 0 million acquisition of Harpoon Therapeutics, harnessing the power of innovation to navigate treat...

Top News

Dow Awaits Key December Jobs Data; Apple Sells Off On Second Downgrade

The Dow Jones was unchanged ahead of December payroll data. Apple got a second downgrade for the week while chip-glut shock drove Mobileye down.

Investors Business Daily

3 Pharma Stock Buys for Last-Minute Year-End Profits

Growing healthcare spending and the use of cutting-edge technologies in the research and development of new drugs have put the pharmaceutical industry in a strong position for growth. With such constructive trends in mind, it's wise to buy fundamentally strong pharma stocks, Merck (MRK), Collegium (COLL) and Johnson & Johnson…

StockNews.com

Looking back on the challenges CEOs faced in 2023, from war to climate change to the A.I. boom

Looking ahead, 2024 likely will be filled with volatility, uncertainty, complexity, and ambiguity. That’s "VUCA" for you.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Are These 3 Pharma Stocks Smart Buys for Bullish Investors?

The pharmaceutical industry's outlook looks promising, given robust healthcare spending worldwide and the rapid adoption of advanced digital technologies. Amid this, let’s find out if pharma stocks AbbVie (ABBV), Collegium Pharmaceutical (COLL), and Merck (MRK) are ideal buys now. Read on to know more….

Investors Business Daily

Stock Market Rally Surges To 2023 Highs As Fed Pivots Toward Rate Cuts: Weekly Review

The Dow Jones hit a record high while the S&P 500, Nasdaq and Russell 2000 set 2023 highs as the Fed signaled multiple rate cuts next year.

Investors Business Daily

Stock Market Erases Gains As Indexes Stumble; Solar Stocks Shine

The Dow Jones index reached another high but the market weakened in afternoon trading. CAT stock jumped.

The Street

Moderna surges on positive skin-cancer-vaccine trial data

The biotech's stock climbs after it reported progress with a skin-cancer vaccine.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Moderna Stock Soars On 'Transformational' Potential Of Its Merck-Tied Cancer Vaccine

Moderna's Merck-partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma patients. Moderna stock soared.

Investors Business Daily

Dow Jones Soars As Fed Chair Powell Gives This Good News; Tesla Rallies As Netflix Nears Entry

The Dow Jones rallied as Fed Chair Powell and the FOMC served up good news. Tesla stock rose despite a recall while Netflix is near an entry.

Investors Business Daily

7 Companies Will Propel Profit More Than 100% Next Year: Analysts

It's only November — but if you're like most investors — 2024 is what matters now. And some S&P 500 companies already look primed to put up big numbers.

StockNews.com

Analyzing Pharma Stock Giants: JNJ, MRK, and ABBV

The pharmaceutical industry is set for long-term growth due to growing demand for quality drugs and therapies, an aging population, and the rise in lifestyle-related diseases. Now, let's explore the investment potential of industry giants Merck & Co (MRK), Johnson & Johnson (JNJ), and AbbVie (ABBV). Keep reading.

Fortune

Former Merck CEO Ken Frazier on the responsibility of CEOs to uphold principles despite politics

Plus: Frazier talks about the shareholders who trusted his vision enough to support him in his early days at the helm.

Barchart

The 3 Best Dow Jones Stocks to Invest in Now, According to Wall Street

Analysts are bullish on these three dividend-paying Dow stocks, with consensus "Strong Buy" ratings and more upside expected for this diverse set of blue chips.

Fortune

Ex-Merck CEO Ken Frazier says CEOs must uphold American values

Frazier was one of the first CEOs to publicly distance himself from President Donald Trump.

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.